The advent of the CRISPR/Cas9 class of genome editing tools is transforming not just science and medicine, but also law. When the genome of germline cells is modified, the modifications could be inherited, with far-reaching effects in time and scale. Legal systems are struggling with keeping up with the CRISPR revolution and both lawyers and scientists are often confused about existing regulations. This book contains an analysis of the national regulatory framework in eighteen selected countries. Written by national legal experts, it includes all major players in bioengineering, plus an analysis of the emerging international standards and a discussion of how international human rights standards should inform national and international regulatory frameworks. The authors propose a set of principles for the regulation of germline engineering, based on international human rights law, that can be the foundation for regulating heritable gene editing both at the level of countries as well as globally.
págs. 1-21
The Governance of Human (Germline) Genome Modification at the International and Transnational Levels
págs. 22-80
págs. 155-216
págs. 217-240
págs. 241-265
págs. 266-280
págs. 281-308
págs. 309-334
págs. 335-357
págs. 358-379
págs. 380-408
págs. 409-438
págs. 441-468
págs. 469-499
págs. 500-515
págs. 516-540
págs. 543-567
págs. 568-582
© 2001-2025 Fundación Dialnet · Todos los derechos reservados